AVTX Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-08-1940001918845-26-000029SEC →
2026-08-1940001810417-26-000019SEC →
2026-08-181440001950047-26-008317SEC →
2026-08-171440001950047-26-008276SEC →
2026-08-171440001950047-26-008273SEC →
2026-08-171440001950047-26-008220SEC →
2026-08-14SCHEDULE 13G/A0001897612-26-000606SEC →
2026-08-14SCHEDULE 13G/A0001727492-26-000021SEC →
2026-08-14SCHEDULE 13G/A0001231919-26-000918SEC →
2026-08-14SCHEDULE 13G/A0001172661-26-003475SEC →
2026-08-14SCHEDULE 13G/A0001104659-26-097285SEC →
2026-08-14SCHEDULE 13G/A0000921895-26-002164SEC →
2026-08-14SCHEDULE 13G/A0000902664-26-003460SEC →
2026-08-13SCHEDULE 13G/A0001011438-26-000509SEC →
2026-08-1240002047607-26-000008SEC →
2026-08-1240001918845-26-000026SEC →
2026-08-111440001950047-26-007948SEC →
2026-08-101440001950047-26-007908SEC →
2026-08-07SCHEDULE 13G/A0000315066-26-002249SEC →
2026-08-07SCHEDULE 13G0000093751-26-000415SEC →
2026-08-0610-Q0001534120-26-000049SEC →
2026-08-068-K0001534120-26-000048SEC →
2026-08-06SCHEDULE 13G/A0000315066-26-001940SEC →
2026-07-2940001918845-26-000024SEC →
2026-07-28EFFECT9999999995-26-002480SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Avalo Therapeutics (AVTX) — Filings